Clinical Trial

Comparison Between Using Cardiometry and IVC Collapsibility

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2026 (before its estimated May 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
Sepsis is a life-threatening condition caused by a dysregulated host response to infection, leading to organ dysfunction. Septic shock, a severe form of sepsis, is characterized by persistent hypotension and cellular/metabolic abnormalities despite adequate fluid resuscitation. It is associated with high mortality rates globally, necessitating timely diagnosis and treatment. Fluid resuscitation and vasopressor use are cornerstones of management, but they must be tailored to the individual to prevent complications such as fluid overload.
Trial Details
NCT Number NCT07411469
Lead Sponsor Menoufia University
Conditions Septic Shock
Enrollment 60 participants
Start Date 2025-05-10
Primary Completion 2026-05-10 (estimated)
Study Completion 2026-05-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-13